BÁO CÁO Y HỌC: "PREVALENCE AND CORRELATES OF BEING BULLIED AMONG IN-SCHOOL ADOLESCENTS IN BEIJING: RESULTS FROM THE 2003 BEIJING GLOBAL" DOCX

lung function impairment in women and risk factors in a long-term perspective are scarce. The results of the study suggest that life-style factors such as mental stress, obesity and smoking among women are related to symptoms in the airway and also quality of life in a long-term perspective. Acknowl[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient s[r]

Murray-Lyon IM. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330–333. 35. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 19[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient s[r]

recipients. Clinical Gastroenterol Hepatol. 2005; 10:S125-31 19. Lee W, Dieterich D. Challenges in the management of HIV and hepatitis C virus infection. Drugs. 2004;64(7):693-700 20. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with Human Immuno[r]

Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. Scand J Infect Dis 1991;23:421-424. 7. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C[r]

mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J Biol Chem 2000; 275: 13842 – 8. 14. Ymazaki S, Nishida K, Yoshida Y, et al. Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene 2003; 22:[r]

and severity of disease. Am J Gastroenterol 2001; 96:2957. 10. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35:367. 11. Marchesini G, Brizi M, Morselli-Labate AM, et al. A[r]

2005; 352(20):2049–2060. 15. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005; 142(7):497–505. 16. Mooradian AD. Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treat[r]

association between maternal use of loratadine in early pregnancy and birth of infants with hypospadias was the result of multiple testing. Acknowledgments The study was supported by a grant from K A Wallenberg Foundation, Sweden, to BK. Conflict of interest The authors have declared that no conflic[r]

genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther. 2005; 22: 1033-40. 25. Sapone A, Vaira D, Trespidi S, et al. The clinical role of cytochrome P450 genotypes in Helicobacter pylori management. Am[r]

with compensated cirrhosis due to hepatitis C has been evaluated in several trials, both as the focus of prospective study, as well as in subgroup (post hoc) analyses of large registration trials. Despite the improved efficacy of peginterferons, the sustained virological response (SVR) rate is subop[r]

Acknowledgements This study was supported by grant RO1 CA070867 from the National Institutes of Health. Conflicts of interest The authors have declared that no conflict of interest exists. References 1. Kawate R, Yamakido M, Nishimoto Y, Bennett PH, Hamman RF, Knowler WC. Diabetes mellitus and its v[r]

DHEA-S levels. Additionally, the oldest-old females with lower DHEA-S gained fewer benefits on enhanc-ing motor performance from exercise training. Acknowledgements This research was supported by the National Science Council, ROC, Grant NSC93-2413-H031-004. Conflict of interests The authors have dec[r]

INTRODUCTION Studies using the human hepatocellular carcinoma HCC cell line HepG2 have demonstrated a specific gene expression pattern induced by ethanol different from that observed in [r]

with compensated cirrhosis due to hepatitis C has been evaluated in several trials, both as the focus of prospective study, as well as in subgroup (post hoc) analyses of large registration trials. Despite the improved efficacy of peginterferons, the sustained virological response (SVR) rate is subop[r]

randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140(5):346-55. 27. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992;15(4):567-71. 28. Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chro[r]

12. Stuyver L, et al. Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995, 38: 137-57. 13. Zheng X, et al. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods. J[r]

4. Hadziyannis SJ, Sette HJr., Morgan TR, Balan V, Diago M, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55. 5. Muir AJ, Bornstein JD and Killenberg PG. Peginterferon[r]

English cities: a case-control comparison of possible causal factors. BJU International 1999;84:95-8. 16. Wennerholm UB, Bergh C, Hamberger L, Lundin K, Nilsson L, Wikland M, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod 2000; 15:944-8. 17. Klip H, Verloop J, v[r]